Modern Healthcare Technology Holdings Limited (0919) AI Stock Analysis

• Market Cap: HK$81.40M
• Dividend Yield: N/A
• Average Volume (3M): 286.00K
• Price to Earnings (P/E): 24.4
• Beta (1Y): 0.04
• Revenue Growth: 19.26%
• EPS Growth: N/A
• Country: HK
• Employees: 850
• Sector: Consumer Cyclical
• Sector Strength: 69
• Industry: Personal Products & Services
• EPS (TTM): 0.01
• Shares Outstanding: 904,483,950
• 10 Day Avg. Volume: 406,000
• 30 Day Avg. Volume: 286,000
• PEG Ratio: 0.21
• Price to Book (P/B): 0.45
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 1.75
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 56 Neutral
• Price Target: ―

Modern Healthcare Technology Holdings Limited shows strengths in revenue growth and a stable balance sheet, but significant challenges remain in profitability and technical momentum. The valuation suggests moderate pricing, but the absence of a dividend and negative technical indicators limit the stock's attractiveness. Focusing on improving profitability and reversing negative technical trends could enhance the stock's appeal.

Modern Healthcare Technology Holdings Limited Business Overview & Revenue Model

Company Description

Modern Healthcare Technology Holdings Limited (0919) is a company engaged in the healthcare sector, primarily focusing on the development and distribution of medical equipment and technology solutions. The company aims to enhance healthcare delivery through innovative products and services, catering to hospitals, clinics, and healthcare professionals. Its core offerings include advanced medical devices, healthcare IT solutions, and specialized healthcare services designed to improve patient outcomes and operational efficiency.

How the Company Makes Money

The company generates revenue through the sale of its medical equipment and technology solutions to healthcare providers and institutions. Key revenue streams include the direct sale of medical devices, recurring income from healthcare IT services, and maintenance and support contracts. Additionally, the company may engage in strategic partnerships with healthcare organizations and technology firms to expand its product offerings and market reach. These collaborations can lead to joint ventures or co-development projects, further contributing to the company's earnings. The company's focus on innovation and quality ensures a steady demand for its products and services in the competitive healthcare technology market.

Modern Healthcare Technology Holdings Limited Financial Statement Overview

Summary

The company shows revenue growth and a stable balance sheet but faces profitability issues with continuous net losses. While cash flow management is strong, the decline in free cash flow growth suggests a need for improved margin and profitability.

Income Statement

The company's revenue has shown growth over the past year, increasing by 11.9% from 2023 to 2024. However, profitability is a concern as net income remains negative, reflecting a -2.1% net profit margin in 2024. Gross profit margin improved to 16.8%, but EBIT and EBITDA margins are low at 2.1% and 21% respectively, indicating operational challenges.

Balance Sheet

The company's balance sheet shows moderate leverage with a debt-to-equity ratio of 0.56, indicating manageable debt levels. The equity ratio of 31% implies a healthy equity base relative to total assets. However, return on equity is negative due to losses, which is a potential risk.

Cash Flow

Operating cash flow remains robust, though it has decreased compared to the previous year. Free cash flow also decreased by 48.9%, but the company maintains a positive free cash flow to net income ratio, signaling efficient cash management despite net losses. The operating cash flow to net income ratio is strong, suggesting effective cash conversion from operations.

Breakdown	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement
Total Revenue	454.71M	406.33M	355.59M	431.45M	522.61M
Gross Profit	166.96M	394.72M	341.52M	417.67M	503.69M
EBITDA	95.68M	92.32M	43.96M	255.36M	55.75M
Net Income	-9.57M	-20.61M	-68.81M	125.72M	-31.59M
Balance Sheet
Total Assets	611.04M	561.35M	570.96M	669.04M	620.00M
Cash, Cash Equivalents and Short-Term Investments	193.66M	177.53M	127.53M	234.34M	179.93M
Total Debt	106.57M	40.11M	65.01M	115.07M	80.88M
Total Liabilities	416.65M	357.47M	347.75M	376.15M	467.89M
Stockholders Equity	189.33M	199.77M	219.58M	289.37M	146.79M
Cash Flow
Free Cash Flow	64.08M	125.52M	-29.55M	121.64M	43.91M
Operating Cash Flow	78.66M	139.82M	51.31M	123.88M	63.91M
Investing Cash Flow	8.16M	-13.17M	-79.96M	-2.85M	-20.77M
Financing Cash Flow	-70.60M	-77.31M	-78.46M	-77.89M	-48.80M

Modern Healthcare Technology Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.09
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0919, the sentiment is Positive. The current price of 0.09 is above the 20-day moving average (MA) of 0.08, above the 50-day MA of 0.08, and above the 200-day MA of 0.09, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 64.35 is Neutral, neither overbought nor oversold. The STOCH value of 56.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0919.

Modern Healthcare Technology Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1093	77 Outperform	$105.68B	22.99	13.20%	2.18%	-9.60%	-27.18%
1530	69 Neutral	$75.23B	33.52	14.19%	0.80%	14.36%	33.22%
1177	68 Neutral	$123.40B	65.03	6.14%	1.16%	7.63%	-24.23%
2196	65 Neutral	$71.09B	16.20	6.22%	1.62%	-2.82%	11.93%
3320	62 Neutral	€33.99B	9.36		6.71%	―	―
Sector *	57 Neutral	HK$25.53B	4.08	-2.03%	6.11%	-0.31%	-67.64%
0919	56 Neutral	HK$81.40M	24.38	-2.50%	―	19.26%	―